Plain-English translation of NCT05286619 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing a combination of three medications— (an immunotherapy drug), plus two chemotherapy drugs (platinum and )—to treat head and neck squamous cell carcinoma that has returned or spread to other parts of the body. Researchers want to see whether this medication combination works better or about the same as an older chemotherapy combination, and whether it's safe enough for patients to tolerate.
Currently, doctors use a standard chemotherapy combination (platinum plus a drug called 5-FU) to treat advanced head and neck cancer. This trial exists because researchers believe this new treatment might work better or cause fewer side effects than the current standard approach.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital or clinic every 3 weeks to receive the medication combination as intravenous infusions. would be given first, followed by the two chemotherapy drugs. The chemotherapy portion lasts for about 6 cycles (roughly 4–5 months), but can continue for up to 35 cycles (about 2 years) if it is working. During this time, you would have regular imaging scans every 6 weeks in the first year, then every 9 weeks afterward, to see how well the treatment is working. Blood tests and other safety checks would also happen regularly.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Malaysia